These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28116765)

  • 1. Urinary exosomes as a novel biomarker for evaluation of α-lipoic acid's protective effect in early diabetic nephropathy.
    Sun H; Yao W; Tang Y; Zhuang W; Wu D; Huang S; Sheng H
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28116765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effect of α-Lipoic acid on mitochondria in the kidney of diabetic rats.
    Wang L; Wu CG; Fang CQ; Gao J; Liu YZ; Chen Y; Chen YN; Xu ZG
    Int J Clin Exp Med; 2013; 6(2):90-7. PubMed ID: 23386911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of valsartan combined with α-lipoic acid on renal function in patients with diabetic nephropathy: a systematic review and meta-analysis.
    Sun F; Jiang D; Cai J
    BMC Endocr Disord; 2021 Aug; 21(1):178. PubMed ID: 34465338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
    Zubiri I; Posada-Ayala M; Sanz-Maroto A; Calvo E; Martin-Lorenzo M; Gonzalez-Calero L; de la Cuesta F; Lopez JA; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
    J Proteomics; 2014 Jan; 96():92-102. PubMed ID: 24211404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study.
    Morcos M; Borcea V; Isermann B; Gehrke S; Ehret T; Henkels M; Schiekofer S; Hofmann M; Amiral J; Tritschler H; Ziegler R; Wahl P; Nawroth PP
    Diabetes Res Clin Pract; 2001 Jun; 52(3):175-83. PubMed ID: 11323087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
    Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy.
    Li CJ; Zhang QM; Li MZ; Zhang JY; Yu P; Yu DM
    Chin Med J (Engl); 2009 Nov; 122(21):2580-6. PubMed ID: 19951573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of L-thyroxine substitution on oxidative stress in early-stage diabetic nephropathy patients with subclinical hypothyroidism: a randomized double-blind and placebo-controlled study.
    Chen Y; Wu G; Xu M
    Int Urol Nephrol; 2018 Jan; 50(1):97-103. PubMed ID: 29196928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
    El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
    IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.
    Maheshwari RA; Balaraman R; Sen AK; Seth AK
    Indian J Pharmacol; 2014; 46(6):627-32. PubMed ID: 25538335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel urinary biomarkers in pre-diabetic nephropathy.
    Garg V; Kumar M; Mahapatra HS; Chitkara A; Gadpayle AK; Sekhar V
    Clin Exp Nephrol; 2015 Oct; 19(5):895-900. PubMed ID: 25634253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy.
    Noori N; Tabibi H; Hosseinpanah F; Hedayati M; Nafar M
    Int J Vitam Nutr Res; 2013; 83(2):77-85. PubMed ID: 24491880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary biomarkers in diabetic nephropathy.
    Soltani-Fard E; Taghvimi S; Karimi F; Vahedi F; Khatami SH; Behrooj H; Deylami Hayati M; Movahedpour A; Ghasemi H
    Clin Chim Acta; 2024 Jul; 561():119762. PubMed ID: 38844018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
    Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
    J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.